Sectors
YDES
YD Bio Ltd
3.71
1 x 2.27
1 x 2.38
bid
ask
-
1.09
22.71%
1 @ 06:43 PM
3.70 -0.01 (0.27%)
| Ytd | -69.57% | |
| 1y | -70.32% |
3.10
day range
4.87
1.70
52 week range
25.00
| Open | 4.87 | Prev Close | 4.80 | Low | 3.10 | High | 4.87 | Mkt Cap | 262.78M |
| Vol | 445.20K | Avg Vol | 142.31K | EPS | -0.12 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.16 | Short Ratio | 0.77 | Inst. Own | 0.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.74 | 200-d Avg | 6.94 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-09-29 | Cerity Partners LLC | 32.41K | 429.06K | 0.05% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-09-29 | Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 20.86K | 276.21K | 0.03% |